Catalyst Wire Dossier Catalyst Wire Dossier

VIP152

VIP152 · Vincerx Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIP152, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer [Phase 1]

See pricing